Ingmar Hoerr
Impact in
- Immunology top 2%
- Immunotherapy and Immune Responses
- Infectious Diseases top 2%
- SARS-CoV-2 and COVID-19 Research
- Viral gastroenteritis research and epidemiology
Papers in
-
- RNA Interference and Gene Delivery 9
- DNA and Nucleic Acid Chemistry 2
-
- Immunotherapy and Immune Responses 8
- Immune Cell Function and Interaction 4
- Co-authors
- Steve Pascolo (11 shared papers)Birgit Scheel (11 shared papers)Günther Jung (5 shared papers)Hans‐Georg Rammensee (8 shared papers)Hans‐Georg Rammensee (2 shared papers)Jochen Probst (8 shared papers)Benjamin Weide (4 shared papers)Reinhard Obst (2 shared papers)
- Journals
- European Journal of Immunology (4 papers)Journal of Immunotherapy (2 papers)Cellular and Molecular Life Sciences (2 papers)OncoImmunology (2 papers)Journal for ImmunoTherapy of Cancer (1 paper)
- Partner nations
- GermanyItalySwitzerland
In The Last Decade
Ingmar Hoerr
18 papers receiving 2.2k citations
Ingmar Hoerr's Hit Papers
Peers
Comparison fields: 5 of 75
- Immunology 1.2k
- Infectious Diseases 507
- Molecular Biology 1.7k
- Genetics 507
- Virology 68
Countries citing papers authored by Ingmar Hoerr
This map shows the geographic impact of Ingmar Hoerr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingmar Hoerr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingmar Hoerr more than expected).
Fields of papers citing papers by Ingmar Hoerr
This network shows the impact of papers produced by Ingmar Hoerr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingmar Hoerr. The network helps show where Ingmar Hoerr may publish in the future.
Co-authors
The 25 scholars most cited alongside Ingmar Hoerr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial Hit paper breakdown → | 2017 | 387 |
| 2 | 2009 | 306 | |
| 3 | 2000 | 299 | |
| 4 | 2015 | 220 | |
| 5 | 2008 | 207 | |
| 6 | 2010 | 180 | |
| 7 | 2007 | 169 | |
| 8 | 2005 | 168 | |
| 9 | 2004 | 114 | |
| 10 | 2006 | 92 | |
| 11 | 2006 | 64 | |
| 12 | 2015 | 50 | |
| 13 | 2005 | 28 | |
| 14 | 2005 | 20 | |
| 15 | 2016 | 18 | |
| 16 | 2021 | 5 | |
| 17 | 2000 | 4 | |
| 18 | 2017 | 2 |
About Ingmar Hoerr
Ingmar Hoerr is a scholar working on Molecular Biology, Immunology, Oncology, Infectious Diseases and Ecology, having authored 18 papers that have together received 2.3k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (9 papers), Immunotherapy and Immune Responses (8 papers), Immune Cell Function and Interaction (4 papers), CAR-T cell therapy research (3 papers), DNA and Nucleic Acid Chemistry (2 papers), Viral gastroenteritis research and epidemiology (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Bacteriophages and microbial interactions (2 papers). The work is most often cited by research in Immunology (1.2k citations), Infectious Diseases (507 citations), Molecular Biology (1.7k citations), Genetics (507 citations) and Virology (68 citations). Ingmar Hoerr has collaborated with scholars based in Germany, Italy and Switzerland. Frequent co-authors include Steve Pascolo, Birgit Scheel, Günther Jung, Hans‐Georg Rammensee, Hans‐Georg Rammensee, Jochen Probst, Benjamin Weide, Reinhard Obst, Jean‐Philippe Carralot and Claus Garbe. Their work appears in journals such as European Journal of Immunology, Journal of Immunotherapy, Cellular and Molecular Life Sciences, OncoImmunology and Journal for ImmunoTherapy of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.